A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Human polyomavirus BKPyV and JCPyV serostatus has no impact on women´s human papillomavirus infection outcome
Tekijät: Laine Hanna K., Waterboer Tim, Syrjänen Kari, Grenman Seija, Louvanto Karolina, Syrjänen Stina
Kustantaja: FRONTIERS MEDIA SA
Julkaisuvuosi: 2023
Journal: Frontiers in Cellular and Infection Microbiology
Tietokannassa oleva lehden nimi: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
Lehden akronyymi: FRONT CELL INFECT MI
Artikkelin numero: 1190019
Vuosikerta: 13
Sivujen määrä: 8
ISSN: 2235-2988
eISSN: 2235-2988
DOI: https://doi.org/10.3389/fcimb.2023.1190019
Verkko-osoite: https://doi.org/10.3389/fcimb.2023.1190019
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/180000452
Introduction: Polyomaviruses have both structural and functional similarities with papillomaviruses. Accordingly, their role in human papillomavirus (HPV) associated malignancies has been studied with conflicting results. Our goal was to disclose any association between BK (BKPyV) and/or JC (JCPyV) polyomavirus serology and HPV data derived from Finnish women (327) in a 6-year prospective follow-up.
Methods: Glutathione S-transferase fusion-protein-capture (ELISA) in combination with fluorescent bead technology was used to analyze antibodies to BKPyV and JCPyV. In the longitudinal setting, BKPyV or JCPyV serostatus was related to i) oral- and ii) genital low (LR)- and high risk (HR) HPV DNA detection, iii) HPV16 persistence at both these sites, iv) results of the Pap (Papanicolaou) smear taken at baseline, and v) development of incident CIN (cervical intraepithelial neoplasia) during the follow-up.
Results: Being BKPyV or JCPyV seropositive was not significantly associated with HPV seropositivity to either LR- or HR-genotypes, genital- or oral HPV DNA positivity, persistence of genital- or oral HPV16 infection, grade of Pap smear, or development of incident CIN.
Discussion: Thus, the present study could not provide any confirmation to the concept that co-infections by HPyV and HPV have interactions that impact on the clinical manifestations or outcomes of HPV infections either in the genital tract or in the oral mucosa.
Ladattava julkaisu This is an electronic reprint of the original article. |